Mr Kyle Eric Munro, PA-C | |
2561 Lac De Ville Blvd Ste 200, Rochester, NY 14618-5645 | |
(585) 473-3900 | |
Not Available |
Full Name | Mr Kyle Eric Munro |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 2561 Lac De Ville Blvd Ste 200, Rochester, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386111599 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 25212 (New York) | Secondary |
363A00000X | Physician Assistant | 025212 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Kyle Eric Munro, PA-C 2561 Lac De Ville Blvd Ste 200, Rochester, NY 14618-5645 Ph: (585) 473-3900 | Mr Kyle Eric Munro, PA-C 2561 Lac De Ville Blvd Ste 200, Rochester, NY 14618-5645 Ph: (585) 473-3900 |
News Archive
Most people do their best to avoid mosquitoes. But this summer Rollie Clem will play the wary host to his own homegrown swarm of Aedes aegypti, the yellow fever mosquito. He's made a room ready for them, and even a menu.
Pharmaron Holdings Limited, today announced it completed the acquisition of Bridge Laboratories China. Bridge Laboratories China is the leading contract research organization (CRO) in China providing western standard GLP-compliant toxicology services to pharmaceutical and biotech companies from around the world. With this acquisition, Pharmaron becomes the first integrated CRO in China supporting clients with drug discovery and development processes in support of IND filings. This strategic acquisition strengthens Pharmaron's leading position in the fast-growing, highly dynamic pharmaceutical CRO industry.
SingHealth and Duke-NUS Graduate Medical School, which form Singapore's largest academic healthcare cluster, are joining a new global research network to accelerate the discovery of treatments and cures. They will be signing a memorandum of understanding with the Eureka Institute for Translational Medicine today.
Experts from Europe, the US and Asia will present their research results and discuss how new therapeutical approaches against infectious diseases may look like.
› Verified 2 days ago